NCT06781723

Brief Summary

In a crossover design 10 young healthy adults (20-35 y) will receive stable isotope tracer infusions and perform a single bout of resistance exercise. Immediately after exercise participants will ingest either 246 g of rice and beans or its constituent macronutrients as isolated amino acids, carbohydrates, fiber, and fat. Repeated blood and muscle biopsies will be collected to determine amino acid concentrations, anabolic signaling and myofibrillar protein synthesis rates during the trials.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 7, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 17, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

May 8, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

October 7, 2024

Last Update Submit

May 5, 2025

Conditions

Keywords

proteinmetabolismplant proteinveganprotein synthesiscomplementary proteins

Outcome Measures

Primary Outcomes (2)

  • Myofibrillar protein fractional synthesis rate

    Myofibrillar protein synthesis rates will be assessed during the postabsorptive and postprandial periods of experimental primed-constant stable isotope infusions.

    Basal FSR (from -150 to - 30 min), Postprandial FSR (from -30 to 300min)

  • Plasma Amino Acid Concentrations

    Amino acid concentrations will be assessed in the postabsorptive state (-210, -150, -90, -30, 0 min) and postprandial state (30, 60, 90, 120, 180, 240, 300 min) via LC/MS/MS.

    Post absorptive (-210, -150, -90, -30, 0 min); Post prandial (30, 60, 90, 120, 180, 240, 300 min)

Secondary Outcomes (1)

  • Activation of Anabolic Signaling Targets

    -150 min, -30 min, 300 min

Study Arms (2)

Rice and Beans (COMP)

EXPERIMENTAL

Rice and Beans After resistance exercise, participants will ingest a meal of 123g Rice, 123g Black Beans (246 g; 575kcal, 20 g Protein, 121 g Carbohydrate, 0.7 g Fat, 1.78 g Fat)

Behavioral: Resistance ExerciseOther: Rice and Beans

Isolated Nutrients (ISO)

ACTIVE COMPARATOR

This condition is isonitrogenous and a similar nutrient profile to the experimental complementary mixed meal. The drink is comprised of crystalline amino acids, carbohydrate, fat, and fiber that is matched to rice and beans meal composition.

Behavioral: Resistance ExerciseDietary Supplement: Isolated Mixture

Interventions

Participants will perform leg press and leg extension immediately prior to ingestion of rice and beans or isolated mixture.

Isolated Nutrients (ISO)Rice and Beans (COMP)
Isolated MixtureDIETARY_SUPPLEMENT

Participants will ingest isolated mixture of crystalized amino acids, maltodextrin, fiber and oil immediately after resistance exercise.

Also known as: ISO
Isolated Nutrients (ISO)

Participants will ingest cooked rice and beans meal immediately after resistance exercise.

Rice and Beans (COMP)

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20-35 yrs
  • Pre-menopausal
  • Recreationally-active
  • Weight stable for prior 6 months

You may not qualify if:

  • Age outside of range (20 - 35 yrs)
  • Pregnancy
  • Irregular menstrual cycles (i.e., \~21 day or \~35 day cycle)
  • Participation in previous research using \[13C6\]phenylalanine
  • Participation in other ongoing research that interferes with this study (e.g., conflicting diet, activity interventions, etc.)
  • Any hospitalization or surgery for a metabolic, cardiovascular, or neuromusculoskeletal complication within the past year
  • Allergy or hypersensitivity to local anesthetics, latex, or adhesives (bandages, medical tape, etc.)
  • Excess scarring after injury
  • History of excess bleeding after cut
  • Chronic or frequent dizziness/fainting, and arm or leg weakness/numbness
  • Arthritis
  • Tumors
  • Mental Illness
  • Hepatorenal, cardiovascular musculoskeletal, autoimmune, or neurological disease or disorder
  • Predisposition to hypertrophic scarring or keloid formation
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Louise Freer Hall

Urbana, Illinois, 61801, United States

Location

MeSH Terms

Interventions

Resistance Training

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized crossover design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 7, 2024

First Posted

January 17, 2025

Study Start

September 5, 2024

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

May 8, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Because it is not planned to published in any ICMJE journal.

Locations